BULLETINNominations Sought for Invitational AwardsThe HMS Faculty Fellowship Committee is accepting nominations for postdoctoral and faculty fellowships and grants offered by more than 50 private foundations. HMS has been invited to select a limited number of individuals for each award to represent Harvard in the national competitions. A summary of these awards (the Red Book) can be reviewed in the offices of departments, full professors, research administration, and women's careers; the Center of Excellence in Women's Health; the office of the dean for faculty development and diversity; and the office of the dean for faculty affairs. The Red Book can also be viewed online. The deadline for nominations is April 8, and all postdoctoral fellows and faculty members are uged to review the information as soon as possible. Potential applicants should discuss the relevant awards with their faculty sponsors or mentors who, with the consent of their department or division heads, make the nominations to the Faculty Fellowship Committee. Direct inquiries to Roslyn Orkin at 432-3579 or Roslyn_Orkin@hms.harvard.edu or to Patricia Stinson at 432-3191 or Patricia_Stinson@hms.harvard.edu.
New Appointments to Full or Named ProfessorshipsThese faculty members were appointed to a full professorship in December. Carol Benson
Professor of Radiology
Brigham and Women's Hospital
Benson is director of ultrasound and codirector of high risk obstetrical ultrasound at Brigham and Women's Hospital, where she also cofounded the multidisciplinary Thyroid Nodule Clinic. Her research interests include prenatal sonographic evaluation of fetal growth disturbances, sonographic detection of fetal anomalies, and sonographic diagnosis of thyroid cancer. She is president of the Society of Radiologists in Ultrasound. Seth Alper
Professor of Medicine
Beth Israel Deaconess Medical Center
Alper is in the Molecular Medicine and Renal Units at Beth Israel Deaconess Medical Center. His lab investigates the physiology, pathophysiology, and genetics of ion transporters and channels that regulate intracellular pH and cell volume, including Cl/HCO3 and Na/H exchangers, potassium transporters and channels, and calcium-permeable cation channels. The understanding of these transport activities has implications for treatment of renal tubular acidosis, sickle cell disease, diarrheal disease, polycystic kidney disease, and for cellular recovery from ischemic injury. David Pauls
Professor of Psychiatry
Massachusetts General Hospital
Pauls is director of the new Unit of Psychiatric and Neurodevelopmental Genetics at Massachusetts General Hospital. The focus of his research is the genetic and environmental mechanisms involved in the development of mental and neurodevelopmental disorders. His work examines components of the clinical phenomenology and their transmission within families and employs clinical, quantitative, and molecular genetic approaches. Four developmental neuropsychiatric disorders are currently involved in his research: the Gilles de la Tourette syndrome (GTS), obsessive compulsive disorder (OCD), high functioning autism/Asperger's syndrome, and specific reading disability. Mark Aronson
Professor of Medicine
Beth Israel Deaconess Medical Center
As a preceptor in Health Care Associates and in his role as chief of the George Kurland Firm, Aronson has long been involved in the education of medical students and residents. He directs the Department of Medicine Hospital Medicine Service and is associate chief of the Division of General Medicine and Primary Care. His research interests have focused on cost-effective utilization of diagnostic tests, and he is co-editor in chief of the adult medicine and primary care section of Up-To-Date in Medicine, an online medical text. Daniel Haber
Professor of Medicine
Massachusetts General Hospital
Haber is an oncologist and cancer geneticist, with particular interest in the genetics of Wilms tumor and breast cancer. His laboratory has published extensively on the function of the WT1 tumor suppressor gene and on the roles of the BRCA and CHK2 genes in genetic predisposition to breast cancer. Haber is director of the Center for Cancer Risk Analysis at the Massachusetts General Hospital Cancer Center and chair of the Cancer Genetics Program for the Dana-Farber/Harvard Cancer Center. He also serves as associate chief for research of the Hematology Oncology Unit at MGH, and as genetics editor for the New England Journal of Medicine. These professors were appointed to a named professorship in December. Harry Rubash
Edith M. Ashley Professor of Orthopedic Surgery
Massachusetts General Hospital
Rubash is chief of Orthopedic Surgery at Massachusetts General Hospital. His research interests straddle the disciplines of clinical medicine and basic science with an emphasis on better understanding the biomechanics and failure mechanisms of total joint arthroplasty (TJA) in the hip and knee. Rubash is particularly interested in revision total hip arthroplasty with major bone loss, revision total knee arthroplasty with component malalignment and infection, and avascular necrosis of the hip. He has developed several new reconstructive techniques for total hip arthroplasty, acetabular and femoral component revisions, revision knee surgeries, and periprosthetic osteolysis. David Sugarbaker
Richard E. Wilson Professor of Surgical Oncology
Brigham and Women's Hospital
Sugarbaker completed his surgery residency at Brigham and Women's Hospital as chief surgical resident and
cardiothoracic training at Toronto General Hospital. He was appointed the first chief of the Division of Thoracic Surgery at BWH in 1988. Sugarbaker's research interests are in National Cancer Institute-sponsored clinical cancer trials and translational research. He is particularly interested in studies looking at new treatments for malignant pleural mesothelioma. Sugarbaker is director of the Dana-Farber Cancer Institute/ Brigham and Women's Hospital Tissue Bank, chief of surgical services, and the Philip L. Lowe senior surgeon at Dana-Farber.
In MemoriamLeo Krall, one of the founders of Joslin Diabetes Center and an HMS lecturer on medicine, died Jan. 30. He was 87.
Krall was an international leader in diabetes for half a century. At the request of Elliot Joslin, Krall joined the team of physicians in 1947 who established Joslin. A frequent traveler and lecturer during his career, Krall was particularly interested in disseminating information on diabetes to developing countries. He founded and directed the Joslin International Fellows Program, which helps train diabetes clinicians worldwide. His accomplishments include serving as director of Joslin's Education Division, where he developed self-maintenance programs for patients. He also established the Diabetes Research and Education Foundation, which provides seed money for clinicians and researchers, and he served as chair of its board of trustees. In addition to authoring or co-authoring nearly 200 scientific papers and other publications, he edited the Joslin Diabetes Manual. Krall was a past and honorary president of the International Diabetes Federation, a member of the advisory committee of the Canadian Diabetes Association, and a member of the board of overseers at Joslin. His honors include the American Diabetes Association Harold H. Rifkin Medal for distinguished international service in the cause of diabetes; the Upjohn Outstanding Educator in the Field of Diabetes Award; the Latin American Diabetes Association Award of Honor; and special recognition from various countries. In 1998, Krall was presented with the Joslin Achievement Award for exemplary service. He is survived by his wife, Lois; a son, Kenneth of Beverly, Mass.; two daughters, Kristina Cady of Pittsford, Vt., and Katherine Guy of Byfield, Mass.; and six grandchildren. Contributions in his memory may be made to the Leo P. Krall, M.D., International Diabetes Care and Education Fund, Joslin Diabetes Center, Development Office, One Joslin Place, Boston, MA 02115.
| 
